Approach to involuntary movements: Clinical sciences

Approach to involuntary movements: Clinical sciences

2nd semester of 4th grade

2nd semester of 4th grade

Approach to anxiety disorders: Clinical sciences
Generalized anxiety disorder, agoraphobia, and panic disorder: Clinical sciences
Obsessive compulsive disorder (OCD): Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Specific phobia and social anxiety disorder (social phobia): Clinical sciences
Approach to joint pain and swelling: Clinical sciences
Gout: Clinical sciences
Osteoarthritis: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Approach to dyspnea: Clinical sciences
Asthma: Clinical sciences
Chronic obstructive pulmonary disease: Clinical sciences
Chronic kidney disease: Clinical sciences
Coronary artery disease: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Approach to mood disorders: Clinical sciences
Bipolar I, bipolar II, and cyclothymic disorder: Clinical sciences
Major depressive disorder and persistent depressive disorder (dysthymia): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Approach to lower limb edema: Clinical sciences
Congestive heart failure: Clinical sciences
Dyslipidemia: Clinical sciences
Approach to hypertension: Clinical sciences
Essential hypertension: Clinical sciences
Approach to involuntary movements: Clinical sciences
Approach to polyneuropathy: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Obesity (pediatrics): Clinical sciences
Osteoporosis: Clinical sciences
Sleep apnea: Clinical sciences
Substance use disorder: Clinical sciences
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Opioid use disorder: Clinical sciences
Opioid withdrawal syndrome: Clinical sciences
Tobacco use: Clinical sciences
Diabetes mellitus (pediatrics): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Well-patient care (GYN): Clinical sciences
Sports physical (pediatrics): Clinical sciences
Non-accidental trauma and neglect (pediatrics): Clinical sciences
Approach to delay or regression in developmental milestones: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Emergency contraception: Clinical sciences
Reversible contraception: Clinical sciences
Immunizations (pediatrics): Clinical sciences
Well-patient care (adult): Clinical sciences
Well-patient care (geriatrics): Clinical sciences
Intimate partner violence and sexual assault: Clinical sciences
Breast cancer screening: Clinical sciences
Cardiovascular disease screening: Clinical sciences
Cervical cancer screening: Clinical sciences
Colorectal cancer screening: Clinical sciences
Preconception care: Clinical sciences
Skin cancer screening: Clinical sciences
Sexually transmitted infection screening (Family medicine): Clinical sciences
Immunizations (adult): Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Involuntary movements are unintentional body movements that can occur due to various conditions, including metabolic derangements, medication effects, and neurodegenerative conditions. There are several distinct types of involuntary movements, such as tremors, dystonia, myoclonus, and chorea, and the underlying pathology is different for each condition.

Important conditions associated with involuntary movements include those secondary to anti-dopaminergic medications, and neurologic conditions, such as Parkinson disease, Creutzfeldt-Jakob disease, Tourette syndrome, and Huntington disease.

Now, if a patient presents with involuntary movements, first obtain a focused history and physical examination, and order a complete metabolic panel. History reveals body movements that the patient cannot control. The physical exam shows abnormal movements that persist even if you distract the patient, while the complete metabolic panel is normal. These findings are suggestive of movement disorder.

Here’s a clinical pearl! Metabolic derangements can cause different abnormal movements. For example, hypocalcemia can increase membrane excitability of peripheral nerves and cause muscle fasciculations and tetany. Less commonly, hypomagnesemia and hypokalemia can also cause fasciculations and tetany. Lastly, renal or hepatic failure might lead to asterixis, which is flapping of the hands when the arms are outstretched.

Your next step is to assess the use of anti-dopaminergic medications, including antipsychotics, especially first-generation antipsychotics, and anti-emetics, such as metoclopramide. If your patient is taking an anti-dopaminergic medication, diagnose medication-induced movement disorder and determine the type of medication reaction the patient is having.

Let’s start with medication-induced dystonia. These patients report sustained muscle tightening, twisting of the body that typically involves the face and neck, and recent use of an anti-dopaminergic agent within the last few hours to days. On the physical exam, you’ll find sustained muscle contractions, such as torticollis; twisting of the tongue; trismus, which is contraction of the muscles of mastication resulting in lockjaw; or opisthotonus, which refers to an extreme arching of the neck and back. With these findings, diagnose medication-induced dystonia.

Okay, let’s discuss medication-induced Parkinsonism. In this case, patients report slowness, stiffness of movement, and possibly shaky hands at rest and frequent falls. Additionally, they have used an anti-dopaminergic agent in the last few weeks to months. On the physical exam, you’ll observe bradykinesia, rigidity, and, sometimes, rest tremor. In this case, diagnose medication-induced parkinsonism. Remember, patients with medication-induced parkinsonism are less likely to have a tremor than patients with idiopathic Parkinson disease, and the symptoms are more likely to be symmetric.

Finally, let’s look at tardive dyskinesia. Here, history reveals frequent grimacing, lip-smacking, eye blinking, or tongue protrusion and twisting. Patients might also report abnormal twisting or posturing of the limbs or body. This type of involuntary movement occurs when anti-dopaminergic medications have been used for months to years. Next, the physical exam reveals repetitive stereotyped movements of the perioral region, extremities, and/or trunk. In this situation, you can diagnose tardive dyskinesia.

Here’s a clinical pearl! Treatment for medication-induced movement disorders involves cessation of the offending agent and benzodiazepine. Keep in mind that unlike medication-induced dystonia and Parkinsonism, tardive dyskinesia may not resolve after stopping the medication.

Alright, let’s switch gears and discuss situations in which an anti-dopaminergic agent was not used. In this case, your next step is to assess if the main involuntary movement is a tremor. If it is, detailed history and physical exam will give you clues about the underlying cause, which most commonly includes Parkinson disease and essential tremor.

Patients with Parkinson disease report shaky hands at rest, slowness of movement, sometimes in combination with frequent falls, and a loss of smell. The physical exam reveals bradykinesia, which is slowness of movement and a decrease in amplitude or speed with continued movement. Additionally, you’ll notice a pill-rolling tremor at rest and rigidity.

Moreover, if you passively move the patient’s limb, you might feel a series of stops or stalls, which is known as cogwheeling or cog-wheel rigidity. Some patients could also present with facial masking, which refers to an impaired facial expression in response to emotion, shorter stride length, and a stooped posture. At this point, consider Parkinson disease, and start a trial of dopaminergic therapy with levodopa and carbidopa.

Next, assess the supportive criteria for Parkinson disease, which include adequate response to dopaminergic therapy, levodopa-induced dyskinesia, the presence of a rest tremor of a limb, and olfactory loss or cardiac sympathetic denervation. If you find at least two of the four supportive criteria, diagnose Parkinson disease.

Sources

  1. "Movement Disorder Society task force viewpoint: Huntington's disease diagnostic categories" Mov Disord Clin Pract (2019)
  2. "Chapter 21: Tourette’s and tic disorders" Handbook of DSM-5 Disorders in Children and Adolescents, 1st ed. (2017)
  3. "MDS clinical diagnostic criteria for Parkinson's disease" Mov Disord (2015)
  4. "Chapter 359: Acute rheumatic fever" Harrison's Principles of Internal Medicine, 21st ed. (2022)
  5. "Rapidly progressive dementia" Continuum (Minneap Minn) (2022)
  6. "Medication-induced movement disorders" Cambridge University Press (2015)
  7. "Chorea" Continuum (Minneap Minn) (2022)
  8. "Validation of revised international Creutzfeldt-Jakob disease surveillance network diagnostic criteria for sporadic Creutzfeldt-Jakob disease" JAMA Netw Open (2022)